Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).

N, Mehta; A, Kalra; AS, Nowacki; S, Anjewierden; Z, Han; P, Bhat; AE, Carmona-Rubio; M, Jacob; GW, Procop; S, Harrington; A, Milinovich; LG, Svensson; L, Jehi; JB, Young; MK, Chung

doi:10.1001/jamacardio.2020.1855

Public

Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).

Shared by NobleBlocks on Sep 1, 2020 • 12:00 AM UTC

Authors:

Mehta N

Kalra A

Nowacki AS

Abstract

Importance The role of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in the setting of the coronavirus disease 2019 (COVID-19) pandemic is hotly debated. There have been recommendations to discontinue these medications, which are essential in the treatmen...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!